BR112013026491A2 - composição microbiocida, e, dispositivo de liberação de infusão intramamária - Google Patents

composição microbiocida, e, dispositivo de liberação de infusão intramamária

Info

Publication number
BR112013026491A2
BR112013026491A2 BR112013026491A BR112013026491A BR112013026491A2 BR 112013026491 A2 BR112013026491 A2 BR 112013026491A2 BR 112013026491 A BR112013026491 A BR 112013026491A BR 112013026491 A BR112013026491 A BR 112013026491A BR 112013026491 A2 BR112013026491 A2 BR 112013026491A2
Authority
BR
Brazil
Prior art keywords
delivery device
intramammary infusion
microbiocidal composition
infusion delivery
contamination
Prior art date
Application number
BR112013026491A
Other languages
English (en)
Other versions
BR112013026491B1 (pt
Inventor
Paul Mccay
Vincent O' Flaherty
Original Assignee
Nat Univ Ireland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Univ Ireland filed Critical Nat Univ Ireland
Publication of BR112013026491A2 publication Critical patent/BR112013026491A2/pt
Publication of BR112013026491B1 publication Critical patent/BR112013026491B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pulmonology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)

Abstract

composição microbiocida, e, dispositivo de liberação de infusão intramamária o presente pedido refere-se a um sistema antimicrobiano para o uso no tratamento de infecções microbianas ou controle de contaminação microbiana, que evita o uso de antibióticos. tais infecções incluem mastite, tuberculose, fibrose cística e a contaminação que pode resultar da formação de biopelícula sobre os dispositivos médicos.
BR112013026491-8A 2011-04-15 2012-04-16 Dispositivo de liberação de infusão intramamária BR112013026491B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11162678.4 2011-04-15
EP11162678A EP2510944A1 (en) 2011-04-15 2011-04-15 Treatment of bacterial infections
PCT/EP2012/056946 WO2012140272A1 (en) 2011-04-15 2012-04-16 Treatment of microbial infections

Publications (2)

Publication Number Publication Date
BR112013026491A2 true BR112013026491A2 (pt) 2016-09-06
BR112013026491B1 BR112013026491B1 (pt) 2022-02-08

Family

ID=44322681

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013026491-8A BR112013026491B1 (pt) 2011-04-15 2012-04-16 Dispositivo de liberação de infusão intramamária

Country Status (9)

Country Link
US (2) US10828349B2 (pt)
EP (3) EP2510944A1 (pt)
JP (1) JP6510233B2 (pt)
CN (2) CN103648522A (pt)
AU (4) AU2012241705A1 (pt)
BR (1) BR112013026491B1 (pt)
CA (1) CA2833078A1 (pt)
PL (1) PL2696890T3 (pt)
WO (1) WO2012140272A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103747770A (zh) 2011-06-15 2014-04-23 Rls全球股份公司 龋牙本质组织的检测和除去
SE536581C2 (sv) 2012-07-24 2014-03-11 Rls Global Ab Ett kit för behandling av sår eller liknande och ett preparat och metoder därav
EP2799068A1 (en) 2013-05-01 2014-11-05 National University of Ireland, Galway Antimicrobial compositions and methods for their production
CN105120681A (zh) * 2013-05-08 2015-12-02 诺维信公司 动物饲料酶
JP6825913B2 (ja) 2014-04-30 2021-02-03 マトケ・ホールディングス・リミテッド 抗菌組成物
EP2987408A1 (en) * 2014-08-20 2016-02-24 National University of Ireland, Galway Iodophor composition with improved stability in the presence of organic material
US20180023217A1 (en) * 2015-02-03 2018-01-25 Matoke Holdings Limited Antimicrobial fibers and compositions
GB201518348D0 (en) * 2015-10-16 2015-12-02 Systagenix Wound Man Ip Co Bv Composition
US20180280340A1 (en) * 2017-03-30 2018-10-04 Konstantin Zubovskiy Method of treating and preventing infections
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
GB2589863A (en) * 2019-12-09 2021-06-16 Institute Of Tech Sligo Antimicrobial composition
JP7379692B2 (ja) 2020-05-11 2023-11-14 株式会社日立ハイテク 自動分析装置および反応容器の挿入方法
GB2609445A (en) 2021-07-30 2023-02-08 Glasport Bio Ltd Compositions and methods
EP4309500A1 (en) * 2022-07-18 2024-01-24 Acies Bio d.o.o. Peroxidase based biocontrol agents
WO2024017883A1 (en) * 2022-07-18 2024-01-25 Acies Bio D.O.O. Peroxidase based biocontrol agents

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011312A (en) * 1975-06-25 1977-03-08 American Home Products Corporation Prolonged release drug form for the treatment of bovine mastitis
LU85479A1 (fr) 1984-07-25 1986-02-12 Oleofina Sa Compositions antibacteriennes de nourriture pour animaux et procede pour les preparer
US4726945A (en) 1986-06-17 1988-02-23 Colgate-Palmolive Co. Hair rinse conditioner
SE8702831L (sv) * 1987-07-10 1989-01-11 Ewos Ab Microbicid komposition
GB9002422D0 (en) 1990-02-03 1990-04-04 Boots Co Plc Anti-microbial compositions
US5888505A (en) * 1991-02-21 1999-03-30 Eoe, Inc. Method for selectively inhibiting the growth of microbes using a haloperoxidase-halide-peroxide system
NL9401048A (nl) * 1994-03-31 1995-11-01 Stichting Scheikundig Onderzoe Haloperoxidasen.
US5575993A (en) * 1994-08-31 1996-11-19 Buckman Laboratories International, Inc. Ionene polymers containing biologically-active anions
US5849291A (en) * 1994-10-17 1998-12-15 Symbollon Corporation Opthalmic non-irritating iodine medicament
BR9707836A (pt) * 1996-03-06 1999-07-27 Novo Nordisk Processos para inibir microorganismo presentes na lavagem de roupas e crescimento microbiano sobre uma superfície dura e para exterminar células microbianas presentes na pele de seres humanos ou de animais nas membranas mucosas nos dentes em ferimentos nas contusoes ou nos olhos ou para inibir o seu crescimento
ATE221729T1 (de) * 1996-05-09 2002-08-15 Novozymes As Antimikrobielle peroxidase-zusammensetzungen
US6100080A (en) * 1996-12-18 2000-08-08 Novo Nordisk A/S Method for enzymatic treatment of biofilm
GB9708641D0 (en) 1997-04-29 1997-06-18 Knoll Ag Enzyme concentrate
ID23661A (id) * 1997-08-14 2000-05-11 Novo Nordisk As Komposisi antimixroba yang mengandung haloperoksidase sumber halida dan sumber amonium
GB9814547D0 (en) * 1998-07-06 1998-09-02 Knoll Ag Sporicidal composition
CA2373485A1 (en) * 1999-05-14 2000-11-23 Peter Francis Fennessy Microbially resistant compositions
EP1068871A1 (en) * 1999-07-07 2001-01-17 Jean-Paul Perraudin Novel methods and medicament for treating infections diseases involving microbial biofilms
ATE390124T1 (de) * 2002-12-16 2008-04-15 Intervet Int Bv Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin
DE602006003760D1 (de) * 2005-06-13 2009-01-22 Flen Pharma N V Zungen
US20060289354A1 (en) * 2005-06-15 2006-12-28 Buckman Laboratories International, Inc. Method and composition to control the growth of microorganisms in aqueous systems and on substrates
EP1987121B1 (en) * 2006-01-13 2013-03-13 Aseptix Research B.V. Enhanced activity biocidal hyrogen peroxide composition
NZ547859A (en) 2006-06-09 2009-05-31 Dec Int Nz Ltd Treatment method and composition for mastitis
EP1872791A1 (en) 2006-06-30 2008-01-02 Institut Pasteur Use of bacterial polysaccharides for biofilm inhibition
GB0619786D0 (en) 2006-10-06 2006-11-15 Inst Of Technology Sligo An antimicrobial and immunostimulatory system
EP2073836A4 (en) * 2006-10-10 2010-04-07 Laclede Inc METHODS AND COMPOSITIONS FOR THE TREATMENT OF VAGINAL DISEASES USING ENZYMES PRODUCING PEROXIDE AND PEROXIDASES
US20080299103A1 (en) * 2007-06-01 2008-12-04 Liliana George Well Preserved Aqueous Organic Compositions
AU2008275542B2 (en) * 2007-07-06 2014-06-05 Laclede, Inc. Use of hydrolytic and oxidative enzymes to dissolve biofilm in airway passages
CA2702796A1 (en) * 2007-10-23 2009-04-30 Novozymes A/S Methods for killing spores and disinfecting or sterilizing devices
ES2581387T3 (es) * 2008-03-26 2016-09-05 Institute Of Technology Sligo Una composición antimicrobiana
US8945540B2 (en) * 2008-05-09 2015-02-03 Exoxemis, Inc. Compositions for enhancing the antibacterial activity of myeloperoxidase and methods of use thereof
NZ600269A (en) * 2009-05-20 2014-02-28 Dec Int Nz Ltd Delivery device for treatment of mastitis
EP2512504A4 (en) 2009-12-15 2013-06-19 Dec Int Nz Ltd COMPOSITION AND THERAPEUTIC METHOD

Also Published As

Publication number Publication date
EP2696890A1 (en) 2014-02-19
EP3888673A1 (en) 2021-10-06
CN103648522A (zh) 2014-03-19
AU2012241705A1 (en) 2013-10-31
US10828349B2 (en) 2020-11-10
JP2014510777A (ja) 2014-05-01
CN108704121A (zh) 2018-10-26
PL2696890T3 (pl) 2021-12-27
JP6510233B2 (ja) 2019-05-08
AU2017202893A1 (en) 2017-05-18
BR112013026491B1 (pt) 2022-02-08
NZ616550A (en) 2016-04-29
US20140134213A1 (en) 2014-05-15
WO2012140272A1 (en) 2012-10-18
EP2510944A1 (en) 2012-10-17
CA2833078A1 (en) 2012-10-18
EP2696890B1 (en) 2021-03-03
AU2021203874A1 (en) 2021-07-08
AU2019202045A1 (en) 2019-04-18
US20210106663A1 (en) 2021-04-15
AU2019202045B2 (en) 2021-04-15

Similar Documents

Publication Publication Date Title
BR112013026491A2 (pt) composição microbiocida, e, dispositivo de liberação de infusão intramamária
BR112015027699A2 (pt) Uso de robenidina ou um sal terapeuticamente aceitável da mesma, composição farmacêutica antibacteriana e dispositivo médico
BR112014000665A2 (pt) composto, uso do mesmo, composição farmacêutica, agente antimicrobiano, e, método para previnir ou tratar uma infecção bacteriana
BR112014022214A2 (pt) fenólicos antibacterianos
SV2016005274A (es) Compuestos orgánicos de monobactam para el tratamiento de infecciones bacterianas
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
BRPI1012219A2 (pt) produto, substrato, composição farmacêutica, usos de um produto, e de um peptídeo antimicrobiano, métodos para prevenir formação de biofilme em um ambiente, para tratar uma infecção microbiana por profilaxia ou terapia, e para tratar ou prevenir formação de biofilme em um ambiente, e, uso de uma cisteamina
NI201500135A (es) Composición farmacéutica de hidrocloruro de s-ketamina
WO2015066647A3 (en) Ionic liquids for transdermal drug delivery
CL2012003281A1 (es) Uso de compuestos específicos estimuladores y/o activadores de sgc; formulacion farmaceutica que comprende dichos compuestos; kit que comprende los compuestos, y uso para la prevencion y/o tratamiento de la esclerosis sistematica.
PE20160052A1 (es) Composicion farmaceutica de clorhidrato de s-cetamina
BR112013008601A8 (pt) Formulações de emulsão de clevidipina contendo agentes antimicrobianos
NZ713946A (en) Combination therapy comprising oxazolidinone-quinolones for use in treating bacterial infections
BR112017005209A2 (pt) compostos moduladores de pirrolopiridina substituída por metila e trifluorometila de rorc2 e seu uso
CL2015002755A1 (es) Composiciones antibióticas de ceftolozano.
CL2012003266A1 (es) Polisacarido de semillas de tamarindo para usarse en el tratamiento de infecciones microbianas; composicion farmacéutica y/o dermocosmética antimicrobiana que contiene dicho polisacárido; uso de un polisacárido de semilla de tamarindo ; metodo para tratar y/o prevenir a un paciente que tiene una infeccion microbiana.
BR112014004704A2 (pt) compostos antibacterianos e métodos de uso
BR112017004153A2 (pt) métodos para tratamento de infecções por protozoários
BR112017003745A2 (pt) inibidores de semialdeído descarboxilase de ácido alfa-amino-beta-carboximucônico
EP3932917A3 (en) Substituted phenyloxazolidinones for antimicrobial therapy
BR112017012406A2 (pt) formulação com relação fixa de insulina glargina/lixisenatida
BR112015006051A2 (pt) usos inéditos
BR112015026193B8 (pt) Composição farmacêutica, método para formular uma composição farmacêutica, uso da composição farmacêutica, método para inibir a formação de biofilme em uma superfície, e, artigo fabricado para curativo
BR112012024999A2 (pt) combinação e uso
EP3292765A4 (en) ANTIBACTERIAL COMPOSITION FOR THE CONTROL OF CARBAPENEMA-RESISTANT GRAM NEGATIVE BACTERIA COMPRISING AN ADK PROTEIN AS ACTIVE INGREDIENT

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08G Application fees: restoration [chapter 8.7 patent gazette]
B08H Application fees: decision cancelled [chapter 8.8 patent gazette]
B08H Application fees: decision cancelled [chapter 8.8 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/04/2012, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 11A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2718 DE 07-02-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.